MiNK Therapeutics, Inc.INKTNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-59.10%
↓ 1032% below average
Average (5y)
-5.22%
Historical baseline
Range
High:65.51%
Low:-59.10%
Volatility
-2386.9%
Relatively stable
| Period | Value |
|---|---|
| 2024 | -59.10% |
| 2023 | -32.99% |
| 2022 | 65.51% |
| 2021 | 46.87% |
| 2020 | -51.62% |
| 2019 | 0.00% |